AGILE THERAPEUTICS INCAGRX

時価総額
$379.3万
PER
2014年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
Net loss----28-20-19-52-75-25
Noncash inventory reserve-------5-
Depreciation12,55100000021
Amortization-----0000
Loss on disposition of assets---------11
Share-based Compensation133442332
Paid-in-Kind Interest------122
Unrealized gain on warrants-348,4300-0-0-0----26
Accounts receivable------112
Inventory-------60
Prepaid expenses and other assets21-1-2-0021-1
Accounts payable and accrued expenses310-2-1145-1
Lease liability-----00131,0000
Net cash used in operating activities----25-17-16-47-65-36
Purchases of marketable securities------55--
Sales and maturities of marketable securities------1540-
Acquisition of property and equipment95,73900100000
Net cash (used in) provided by investing activities----1-0-0-4139-0
Proceeds from Issuance of Preferred Stock and Preference Stock--------4
Proceeds from Issuance Initial Public Offering50-38-----22
Proceeds from At-the-Market sales of common stock, net of offering costs-------913
Proceeds from issuance of long-term debt------20--
Repayments of long-term debt--------17
Debt financing costs paid150,00000---1--
Proceeds from Stock Options Exercised67,288100-010-
Net cash provided by financing activities---13-1142683022
Net (decrease) increase in cash and cash equivalents-----2827-205-14
Warrants issued in connection with long-term debt------41-
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability-------1-
Interest paid---11-221